News & Events

featured

BioLamina appoints Brian Hawkins, PhD as new Chief Technology Officer (CTO).

Stockholm, March 3, 2025 BioLamina appoints Brian Hawkins, PhD, as new Chief Technology Officer (CTO). BioLamina AB, appoints Brian Hawkins […]

featured

Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx

Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx We are proud to have been chosen by PluriStyx […]

events

Webinar: Treating Blindness with Stem Cell Therapies

How close are we to one-shot stem cell therapies for eye disease? What are the critical factors for successful translation to the clinic? Join us for the panel discussion!

featured

BioLamina AB appoints Klaus Langhoff-Roos as new CEO.

Stockholm August 15, 2024 BioLamina appoints Klaus Langhoff-Roos as new CEO. BioLamina AB, a leading maker of reagents for stem […]